ドイツの感染症検査市場

◆英語タイトル:Germany Infectious Diagnostics Market Outlook to 2021
◆商品コード:GDMECC1227DB
◆発行会社(リサーチ会社):GlobalData
◆発行日:2015年9月1日
◆ページ数:53
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥540,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥810,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Germany Infectious Diagnostics Market Outlook to 2021

Summary

GlobalData’s new report, “Germany Infectious Diagnostics Market Outlook to 2021″, provides key market data on the Germany Infectious Diagnostics market. The report provides value, in millions of US dollars within market segments – Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Infectious Diagnostics market includes Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Infectious Diagnostics market.
- Global corporate-level profiles of key companies operating within the Germany Infectious Diagnostics market.
- Key players covered include Siemens Healthcare, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Hologic, Inc., Qiagen N.V., Becton, Dickinson and Company, Danaher Corporation and Alere Inc..

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Infectious Diagnostics Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Infectious Diagnostics Market, Germany 8
3.1 Infectious Diagnostics Market, Germany, Revenue ($m), 2007-2014 8
3.2 Infectious Diagnostics Market, Germany, Revenue ($m), 2014-2021 10
3.2.1 Infectious Diagnostics Rapid Tests & POC Market, Germany, Revenue ($m), by Segment, 2007-2014 12
3.2.2 Infectious Diagnostics Rapid Tests & POC Market, Germany, Revenue ($m), by Segment, 2014-2021 14
3.3 Infectious Diagnostics Market, Germany, Distribution Share by Revenue ($m), 2013-2014 16
3.4 Infectious Diagnostics Market, Germany, Company Share by Revenue ($m), 2014 17
4 Overview of Key Companies in Germany, Infectious Diagnostics Market 19
4.1 Siemens Healthcare 19
4.1.1 Company Overview 19
4.2 Abbott Laboratories 19
4.2.1 Company Overview 19
4.3 Qiagen N.V. 19
4.3.1 Company Overview 19
4.4 DiaSorin S.p.A 20
4.4.1 Company Overview 20
4.5 Bio-Rad Laboratories, Inc. 20
4.5.1 Company Overview 20
4.6 F. Hoffmann-La Roche Ltd. 20
4.6.1 Company Overview 20
4.7 bioMerieux S.A. 21
4.7.1 Company Overview 21
4.8 Alere Inc. 21
4.8.1 Company Overview 21
5 Infectious Diagnostics Market Pipeline Products 22
6 Financial Deals Landscape 34
6.1 Acquisition 34
6.1.1 Orgentec Diagnostika to Acquire Corgenix Medical for USD16 Million 34
6.2 Partnerships 36
6.2.1 Biocartis Enters into Licensing and Development Agreement with Microbiome 36
6.3 Venture Financing 37
6.3.1 Curetis Raises USD18 Million in Extended Series B Venture Financing 37
7 Recent Developments 40
7.1 Corporate Communications 40
7.1.1 May 11, 2015: Curetis Strengthens Executive Team; Appoints Dr. Achim Plum as Chief Commercial Officer 40
7.2 Financial Announcements 41
7.2.1 Mar 24, 2015: Biotest increases sales by 16.2% 41
7.2.2 Mar 19, 2015: AHN Offers Innovative Minimally-Invasive Surgical Procedure for Patients with Common, Yet Difficult to Diagnose, Form of Recurring Back Pain 41
7.2.3 Mar 18, 2015: Blue Belt Technologies Announces First Navio Case Performed in Australia and First Navio-assisted GRU Unicompartmental Knee Replacement 42
7.2.4 Mar 17, 2015: LG Health receives first upgrade to its CyberKnife M6 System 44
7.2.5 Mar 17, 2015: Mediware to Unveil CareTend Software at NHIA Conference 44
7.2.6 Feb 13, 2015: Biotest increases revenues significantly by 16.2% 46
7.2.7 Feb 12, 2015: FDA Classifies Previous Covidien Field Action for Its Trellis-6 Peripheral Infusion Systems As a Class 1 Recall 46
7.2.8 Nov 12, 2014: Biotest Increases Sales By 11,5% Compared To Previous Year 47
7.3 Other Significant Developments 47
7.3.1 May 07, 2015: Biotest increases revenues by 16,6% 47
7.4 Product News 48
7.4.1 Oct 22, 2014: m2p-labs Supports Research Project in Synthetic Biology 48
7.5 Strategy And Business Planning 49
7.5.1 Apr 20, 2015: Curetis Expands Commercial Organization 49
8 Appendix 50
8.1 Research Methodology 51
8.1.1 Coverage 51
8.1.2 Secondary Research 51
8.1.3 Primary Research 51
8.1.4 Company Share Analysis 52
8.1.5 Distribution Share Analysis 52
8.2 GlobalData Consulting 52
8.3 Contact Us 52
8.4 Disclaimer 53

1.1 List of Tables
Table 1: Infectious Diagnostics Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 9
Table 2: Infectious Diagnostics Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 11
Table 3: Infectious Diagnostics Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 13
Table 4: Infectious Diagnostics Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 15
Table 5: Infectious Diagnostics Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2013-2014 16
Table 6: Infectious Diagnostics Market, Germany, Company Share by Revenue ($m), USD Constant, 2014 18
Table 7: Infectious Diagnostics Market Pipeline Products 22
Table 8: Orgentec Diagnostika to Acquire Corgenix Medical for USD16 Million 34
Table 9: Biocartis Enters into Licensing and Development Agreement with Microbiome 36
Table 10: Curetis Raises USD18 Million in Extended Series B Venture Financing 37

1.2 List of Figures
Figure 1: Infectious Diagnostics Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 8
Figure 2: Infectious Diagnostics Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 10
Figure 3: Infectious Diagnostics Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 12
Figure 4: Infectious Diagnostics Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 14
Figure 5: Infectious Diagnostics Market, Germany, Company Share (%) 2014 17

【掲載企業】

Siemens Healthcare
Abbott Laboratories
Qiagen N.V.
DiaSorin S.p.A
Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche Ltd.
bioMerieux S.A.
Alere Inc.

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ドイツの感染症検査市場(Germany Infectious Diagnostics Market Outlook to 2021)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆